Mean percentage change in natural killer cell activity from a baseline level baseline (prior to the initial dose) , week 8, and week 14 [clinicaltrials_resource:a1b3f020c539f4d75eec33ed1bae6fc3]
Laboratory measurements included blood chemistry (BC), complete blood count (CBC), and urinalysis
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Mean percentage change in natural killer cell activity from a baseline level baseline (prior to the initial dose) , week 8, and week 14 [clinicaltrials_resource:a1b3f020c539f4d75eec33ed1bae6fc3]
Laboratory measurements included blood chemistry (BC), complete blood count (CBC), and urinalysis
Bio2RDF identifier
a1b3f020c539f4d75eec33ed1bae6fc3
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a1b3f020c539f4d75eec33ed1bae6fc3
measure [clinicaltrials_vocabulary:measure]
Mean percentage change in natural killer cell activity from a baseline level
time frame [clinicaltrials_vocabulary:time-frame]
baseline (prior to the initial dose) , week 8, and week 14
description
Laboratory measurements includ ...... od count (CBC), and urinalysis
identifier
clinicaltrials_resource:a1b3f020c539f4d75eec33ed1bae6fc3
title
Mean percentage change in natu ...... al dose) , week 8, and week 14
@en
type
label
Mean percentage change in natu ...... 3f020c539f4d75eec33ed1bae6fc3]
@en